Compare Reddit Inc (RDDT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs Recursion Pharmaceuticals Inc — how do they compare? Reddit Inc trades at $147.16 (market cap $28.74B), while Recursion Pharmaceuticals Inc trades at $3.22 (market cap $1.86B). The key difference: Reddit Inc is far larger — about 15.5× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| RDDT | RXRX | |
|---|---|---|
Market Cap | $28.74B | $1.86B |
Sector | Media | Health |
52-Week High | $270.71 | $6.79 |
52-Week Low | $121.84 | $2.84 |
Enterprise Value | $25.97B | $1.38B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $149.38, down 3.29% amid bearish technical signals, though fundamentals remain strong with 61% YoY revenue growth and consistent earnings beats. The stock faces valuation concerns despite robust profitability margins above 30% and positive analyst sentiment with 64% buy ratings. Recent CEO stock sales and AI licensing renewal risks have contributed to recent volatility.
The outlook remains positive with a $216.08 consensus price target suggesting 45% upside potential, driven by AI monetization and international expansion. Key risks include valuation compression, competitive pressures in digital advertising, and the expiration of major AI data licensing agreements in 2027.
RXRX trades at $3.44, down 5.23% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 earnings miss with revenue of $54M and net loss of -$519M, maintaining a negative profit margin of -961.97%. Recent news highlights AI-driven drug discovery progress with Genentech partnership milestones and pipeline expansion in oncology and rare diseases.
Outlook remains speculative with high revenue growth potential from AI platform partnerships offset by persistent losses and cash burn. Investment opportunity hinges on clinical pipeline success, while risks include slow revenue traction and competitive pressures in AI-biotech. Analyst consensus is mixed with 40% buy ratings amid cautious optimism on long-term catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
